Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment.

Multiple sclerosis (Houndmills, Basingstoke, England) - 1 May 2011

Alvarez-Lafuente Roberto, Blanco-Kelly Fiona, Garcia-Montojo Marta, Martínez Alfonso, De Las Heras Virginia, Dominguez-Mozo Maria Inmaculada, Bartolome Manuel, Garcia-Martinez Angel, De la Concha Emilio Gomez, Urcelay Elena, Arroyo Rafael

Abstract excerpt

BACKGROUND: In a prior study of our group we found an up-regulation of CD46 expression in a cohort of Spanish multiple sclerosis (MS) patients. OBJECTIVE: To evaluate the potential role of CD46 in the response to interferon-beta treatment in MS patients through the analysis of five tagging single...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-beta

Share to Membrane Cofactor Protein

Share to Multiple Sclerosis

Share to Patient Selection

Share to Pharmacogenetics

Source

Identifiers

PMID: 21177319
DOI: 10.1177/1352458510393263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21177319-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment.PMID 21177319Read ↗

The multiple sclerosis associated CD226 risk variant alters vitamin D-induced human type I regulatory T cell differentiation by impairing LFA-1 activationSemantic proximity Read ↗

From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16ASemantic proximity Read ↗

A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment.Semantic proximity Read ↗

Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population.Semantic proximity Read ↗

Single-nucleotide polymorphisms in response to interferon-beta therapy in multiple sclerosis.Semantic proximity Read ↗

Effects of HLA-DRA, HLA-DQA1 and IL-6 Gene Variations to Glatiramer Acetate Resistance in Multiple Sclerosis Patients.Semantic proximity Read ↗

Association study of promoter polymorphisms of interferon alpha and beta receptor subunit 1 (IFNAR1) gene and therapeutic response to interferon-beta in patients with multiple sclerosis.Semantic proximity Read ↗

The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.Semantic proximity Read ↗

CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients.Semantic proximity Read ↗

High-resolution melting curve analysis of polymorphisms within CD58, CD226, HLA-G genes and association with multiple sclerosis susceptibility in a subset of Iranian population: a case-control study.Semantic proximity Read ↗

Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.Semantic proximity Read ↗

CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.